Skin Rejuvenation in Massachusetts

Candela Corporation, headquartered in Marlborough, Massachusetts, is an established global medical aesthetic device manufacturer founded in 1970. The company designs and distributes laser, intense pulsed light (IPL), and radiofrequency microneedling systems for dermatologists, aesthetic practitioners, and medical spas. Candela's product portfolio includes pulsed dye lasers (Vbeam Pro, Vbeam Perfecta), Nd:YAG lasers, alexandrite systems (Gentle Pro Series, GentleMax Pro Plus), picosecond lasers (PicoWay), radiofrequency microneedling platforms (Matrix, Exceed), IPL systems (Nordlys), and hydrodermabrasion devices (Glacē). These devices address a broad range of clinical indications including laser hair removal, vascular lesions, pigmented lesions, acne scars, wrinkles, tattoo removal, melasma, rosacea, and skin rejuvenation across all Fitzpatrick skin types. Candela holds FDA clearances for its devices, including pediatric clearance for the Vbeam Pro. The company emphasizes comprehensive customer support including service maintenance, technical training, and clinical education. Candela maintains a global distribution network with offices in Europe, Asia Pacific, and worldwide distributors. The company has received industry recognition including the Manufacturer of the Year Award from Aesthetics Journal and recognition from Cosmopolitan's 2025 Acne Awards for its Matrix RF microneedling system.

WiQo US, Inc. is a US distributor and marketer of PRX by WiQo®, a needle-free skin revitalization system developed through Italian medical-device innovation. The company distributes professional-grade aesthetic treatment products backed by over 20 years of clinical safety and efficacy testing, with deployment in 67 countries and over 8 million treatments performed globally. PRX product lines include PRX Derm Perfexion (general skin revitalization targeting firmness, elasticity, hydration, fine lines, and aging signs; suitable for all skin types including delicate/sensitive skin), PRX PLUS (for mature/textured skin with visible aging, targeting deep wrinkles, enlarged pores, hyperpigmentation), and PRX C (vitamin C formulation for dull, gray, or environmentally stressed skin). The company operates a B2B provider-network model, offering professional certification programs, clinical training, practice development support, and provider locator services. All products are formulated to be needle-free, non-invasive, zero-downtime, safe for all seasons and skin tones, with 20-minute treatment protocols. The company targets dermatologists, aesthetic medicine practitioners, medical spas, and professional skincare clinics seeking advanced, non-invasive skin treatment options.

Jeisys Medical North America Inc. is a Korea-based aesthetic medical device manufacturer and distributor now expanding into the U.S. market. The company specializes in radiofrequency (RF), laser, and energy-based aesthetic devices for skin rejuvenation, resurfacing, and body contouring. Product portfolio includes DENSITY (dual-mode RF system for skin remodeling and collagen building), Potenza (RF microneedling with proprietary Pumping Tip technology), and Edge ONE (non-ablative laser resurfacing system). The company also manufactures IPL (intense pulsed light) devices, CO2 lasers, and Q-switched ND:YAG systems distributed globally. With 25 years of R&D innovation and over 15,000 systems installed worldwide, Jeisys targets aesthetic practices, dermatologists, and medical spas. The company is backed by Archimed, an $8 billion healthcare investment firm, and is led by founder DH Kang and a team of U.S. aesthetics industry veterans. Jeisys emphasizes provider partnerships, hands-on training, clinical support, and real-time troubleshooting. All devices are manufactured to medical-grade standards, though specific FDA, ISO 13485, or 510(k) certifications are not explicitly detailed on the website. The company operates direct distribution in Japan, Australia, Vietnam, and recently entered the U.S. and Brazil markets.

Cynosure Lutronic is a leading medical aesthetics manufacturer specializing in energy-based and light-based treatment systems for dermatological, surgical, and aesthetic applications. Founded in 1991 and merged with Lutronic in 2024, the company develops advanced laser and radiofrequency technologies for hair removal, skin rejuvenation, scar reduction, acne treatment, body contouring, and gynecological health solutions. Their product portfolio includes innovative platforms such as Potenza RF microneedling and XERF RF systems designed to address fine lines, wrinkles, and comprehensive skin and body treatments. Cynosure supports a global network of practitioners including dermatologists, plastic surgeons, dental professionals, and aesthetic business owners with comprehensive technical, clinical, and marketing support services to enhance practice profitability and patient outcomes.

Avava, Inc. is a medical aesthetics company specializing in precision laser and energy-based skin treatment systems. The company's flagship product is the AVAVA® laser platform, which utilizes proprietary Focal Point Technology™ for targeted energy delivery at multiple skin depths and ComfortCool™ integrated cooling technology to enhance patient comfort while minimizing unintended thermal damage to surrounding tissue. The system is designed to address diverse skin tones and skin types, offering personalized skin renewal treatments including resurfacing and revitalization with minimal downtime. The company also develops digital ecosystem solutions including MyAVAVA™ patient engagement software and AVAVASyncPro™ provider management tools. Avava is founded by leading dermatological researchers affiliated with Massachusetts General Hospital and Harvard Medical School, including Dr. R. Rox Anderson (Director of Wellman Center for Photomedicine), Dr. Dieter Manstein, and Dr. Henry H.L. Chan. The company markets its technology to aesthetic providers and clinics globally and operates a provider network model. No FDA clearance status, ISO certification, or CE marking is explicitly mentioned on the fetched website content.